Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases
- PMID: 32781063
- DOI: 10.1016/j.lfs.2020.118182
Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases
Abstract
Background: Chronic diseases are a major cause of mortality worldwide, and despite the recent development in treatment modalities, synthetic drugs have continued to show toxic side effects and development of chemoresistance, thereby limiting their application. The use of phytochemicals has gained attention as they show minimal side effects. Diosgenin is one such phytochemical which has gained importance for its efficacy against the life-threatening diseases, such as cardiovascular diseases, cancer, nervous system disorders, asthma, arthritis, diabetes, and many more.
Aim: To evaluate the literature available on the potential of diosgenin and its analogs in modulating different molecular targets leading to the prevention and treatment of chronic diseases.
Method: A detailed literature search has been carried out on PubMed for gathering information related to the sources, biosynthesis, physicochemical properties, biological activities, pharmacokinetics, bioavailability and toxicity of diosgenin and its analogs.
Key findings: The literature search resulted in many in vitro, in vivo and clinical trials that reported the efficacy of diosgenin and its analogs in modulating important molecular targets and signaling pathways such as PI3K/AKT/mTOR, JAK/STAT, NF-κB, MAPK, etc., which play a crucial role in the development of most of the diseases. Reports have also revealed the safety of the compound and the adaptation of nanotechnological approaches for enhancing its bioavailability and pharmacokinetic properties.
Significance: Thus, the review summarizes the efficacy of diosgenin and its analogs for developing as a potent drug against several chronic diseases.
Keywords: Analogs; Bioavailability; Cancer; Chronic diseases; Dioscin; Diosgenin; Molecular targets; Pharmacokinetics; Toxicology.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Rationalizing the therapeutic potential of apigenin against cancer.Life Sci. 2021 Feb 15;267:118814. doi: 10.1016/j.lfs.2020.118814. Epub 2020 Dec 30. Life Sci. 2021. PMID: 33333052 Review.
-
Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis.Drug Des Devel Ther. 2022 Jul 17;16:2305-2323. doi: 10.2147/DDDT.S368836. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35875677 Free PMC article. Review.
-
Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances.Oxid Med Cell Longev. 2020 Mar 6;2020:3153082. doi: 10.1155/2020/3153082. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215172 Free PMC article. Review.
-
Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review.Nutrients. 2018 May 19;10(5):645. doi: 10.3390/nu10050645. Nutrients. 2018. PMID: 29783752 Free PMC article. Review.
-
Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives.Oxid Med Cell Longev. 2022 May 29;2022:1035441. doi: 10.1155/2022/1035441. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35677108 Free PMC article. Review.
Cited by
-
Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine.Front Endocrinol (Lausanne). 2024 Jul 23;15:1429420. doi: 10.3389/fendo.2024.1429420. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39109083 Free PMC article. Review.
-
Co-Expression Network Analysis and Molecular Docking Demonstrate That Diosgenin Inhibits Gastric Cancer Progression via SLC1A5/mTORC1 Pathway.Drug Des Devel Ther. 2024 Jul 23;18:3157-3173. doi: 10.2147/DDDT.S458613. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39071813 Free PMC article.
-
Development of chitosan-folate modified PLGA nanoparticles for targeted delivery of diosgenin as an anticancer agent.Discov Oncol. 2024 Apr 3;15(1):100. doi: 10.1007/s12672-024-00957-7. Discov Oncol. 2024. PMID: 38568336 Free PMC article.
-
Safety of Innovative Nanotechnology Oral Formulations Loaded with Bioactive Menopause Molecules: Influence of Genotoxicity and Biochemical Parameters on a Menopausal Rat Model.Nutrients. 2023 Nov 29;15(23):4951. doi: 10.3390/nu15234951. Nutrients. 2023. PMID: 38068809 Free PMC article.
-
Literature review on hepatoprotective effects of diosgenin: possible mechanisms of action.Front Pharmacol. 2023 Sep 12;14:1226548. doi: 10.3389/fphar.2023.1226548. eCollection 2023. Front Pharmacol. 2023. PMID: 37767400 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous